These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 11032019

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
    Cataldo L, Chen NY, Yuan Q, Li W, Ramamoorthy P, Wagner TE, Sticca RP, Chen WY.
    Int J Oncol; 2000 Dec; 17(6):1179-85. PubMed ID: 11078803
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel design of targeted endocrine and cytokine therapy for breast cancer.
    Zhang G, Li W, Holle L, Chen N, Chen WY.
    Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
    [Abstract] [Full Text] [Related]

  • 6. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.
    Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE.
    Clin Cancer Res; 1999 Nov; 5(11):3583-93. PubMed ID: 10589775
    [Abstract] [Full Text] [Related]

  • 7. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.
    Bernichtein S, Kinet S, Jeay S, Llovera M, Madern D, Martial JA, Kelly PA, Goffin V.
    Endocrinology; 2001 Sep; 142(9):3950-63. PubMed ID: 11517174
    [Abstract] [Full Text] [Related]

  • 8. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD, Fang H, Xu J, Grimley PM, Rui H.
    Cancer Res; 1998 May 01; 58(9):1914-9. PubMed ID: 9581833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN, Critchley HO, Boddy SC.
    J Clin Endocrinol Metab; 1998 Jul 01; 83(7):2545-53. PubMed ID: 9661641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
    Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY.
    Breast Cancer Res Treat; 2008 Sep 01; 111(2):241-50. PubMed ID: 17955362
    [Abstract] [Full Text] [Related]

  • 15. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ, Pretlow TG, Ealley EL, Zhang Y, Nurmi M, Singh B, Martikainen PM, Nevalainen MT.
    Cancer Res; 2004 Jul 15; 64(14):4774-82. PubMed ID: 15256446
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
    Nouhi Z, Chughtai N, Hartley S, Cocolakis E, Lebrun JJ, Ali S.
    Cancer Res; 2006 Feb 01; 66(3):1824-32. PubMed ID: 16452244
    [Abstract] [Full Text] [Related]

  • 18. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
    Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA, Muller M.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):127-39. PubMed ID: 15607537
    [Abstract] [Full Text] [Related]

  • 19. Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide.
    Langenheim JF, Chen WY.
    J Endocrinol; 2009 Dec 14; 203(3):375-87. PubMed ID: 19770179
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.